FDA – Newsetic

Breakthrough in Alzheimer’s: FDA Approves Donanemab by Eli Lilly

Health

July 8, 2024

Breakthrough in Alzheimer’s: FDA Approves Donanemab by Eli Lilly

The U.S. Food and Drug Administration (FDA) has approved a new drug called donanemab for the treatment of early symptomatic Alzheimer’s disease. This significant development brings hope to many patients and their families. Developed by Eli Lilly, a pharmaceutical company

By Shaw

Diamond Shruumz Chocolate, Cones, and Gummies Linked to Rising Illnesses, FDA Reports

Health

June 14, 2024

Diamond Shruumz Chocolate, Cones, and Gummies Linked to Rising Illnesses, FDA Reports

The US Food and Drug Administration (FDA) has warned consumers and retailers not to “eat, sell, or serve” any of Diamond Shruumz-brand’s micro-dosing chocolate bars, infused cones, and microdose and macro dose gummies. This warning follows reports of hospitalizations across

By Shaw